The first Novo Nordisk trade was made in Q4 2014.
Since then Steven Cohen bought shares seven more times and sold shares on nine occasions. The investor sold all their shares in Q3 2024 and doesn't own any shares in Novo Nordisk anymore.
Avg closing price
Price range
Sold -961 Thousand shares
Q3 2024
Avg closing price
$133.54
Price range
$119.07
-
$145.42
New holding (+961 Thousand shares)
Q2 2024
Avg closing price
$132.51
Price range
$122.71
-
$146.91
Sold -134 shares
Q3 2023
Avg closing price
$164.52
Price range
$90.94
-
$199.54
New holding (+134 shares)
Q2 2023
Avg closing price
$163.37
Price range
$155.98
-
$172.65
Sold -52.5 Thousand shares
Q3 2022
Avg closing price
$107.14
Price range
$95.28
-
$116.93
Sold 95.5% shares (-1.12 Million shares)
Q2 2022
Avg closing price
$110.98
Price range
$103.24
-
$121.81
New holding (+1.17 Million shares)
Q1 2022
Avg closing price
$102.64
Price range
$93.10
-
$112.54
Sold -117 Thousand shares
Q1 2020
Avg closing price
$59.55
Price range
$49.46
-
$64.78
New holding (+117 Thousand shares)
Q4 2019
Avg closing price
$55.37
Price range
$49.86
-
$58.26
Sold -1.66 Million shares
Q2 2019
Avg closing price
$49.42
Price range
$46.79
-
$52.47
Sold 6.7% shares (-120 Thousand shares)
Q1 2019
Avg closing price
$49.15
Price range
$46.36
-
$52.63
New holding (+1.78 Million shares)
Q4 2018
Avg closing price
$44.44
Price range
$41.54
-
$47.25
Sold -592 Thousand shares
Q1 2018
Avg closing price
$52.50
Price range
$48.49
-
$58.14
Increased shares by 98.0% (+293 Thousand shares)
Q4 2017